Putnam Investments LLC Has $1,132,000 Stake in Innocoll Holdings PLC (INNL)
March 21st, 2017 - By Scott Moore - 0 comments
Innocoll Holdings PLC logoPutnam Investments LLC reduced its position in Innocoll Holdings PLC (NASDAQ:INNL) by 23.1% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 1,640,647 shares of the specialty pharmaceutical company’s stock after selling 493,070 shares during the period. Putnam Investments LLC owned about 5.52% of Innocoll Holdings PLC worth $1,132,000 at the end of the most recent quarter.
Separately, Prudential PLC boosted its position in shares of Innocoll Holdings PLC by 19.2% in the fourth quarter. Prudential PLC now owns 1,079,172 shares of the specialty pharmaceutical company’s stock worth $745,000 after buying an additional 173,833 shares during the last quarter. 42.88% of the stock is currently owned by hedge funds and other institutional investors.
Institutional Ownership by Quarter for Innocoll Holdings PLC (NASDAQ:INNL)
Innocoll Holdings PLC (NASDAQ:INNL) opened at 1.12 on Tuesday. The firm’s 50-day moving average is $0.78 and its 200 day moving average is $2.97. Innocoll Holdings PLC has a 1-year low of $0.53 and a 1-year high of $12.94. The company’s market cap is $33.26 million.
Your IP Address: 2003:89:e74:da00:14f2:72da:a5f6:1b3
A number of equities analysts recently issued reports on INNL shares. Janney Montgomery Scott cut shares of Innocoll Holdings PLC from a “buy” rating to a “neutral” rating and set a $2.00 price target on the stock. in a research note on Friday, December 30th. Zacks Investment Research cut shares of Innocoll Holdings PLC from a “buy” rating to a “hold” rating in a research note on Wednesday, November 30th. JMP Securities cut shares of Innocoll Holdings PLC from an “outperform” rating to a “market perform” rating in a research note on Friday, December 30th. FBR & Co cut shares of Innocoll Holdings PLC from an “outperform” rating to a “market perform” rating and upped their target price for the company from $2.00 to $10.00 in a research note on Friday, December 30th. Finally, Stifel Nicolaus cut shares of Innocoll Holdings PLC from a “buy” rating to a “hold” rating and lowered their target price for the company from $9.00 to $2.00 in a research note on Friday. Five investment analysts have rated the stock with a hold rating, Innocoll Holdings PLC currently has an average rating of “Hold” and a consensus price target of $3.69.
About Innocoll Holdings PLC
Innocoll Holdings Public Limited Company is a commercial-stage specialty pharmaceutical and medical device company with late-stage development programs. The Company operates through the segment of manufacture and sale of collagen-based pharmaceutical products. It utilizes collagen-based technology platform to develop its biodegradable and bioresorbable products and product candidates, which can be broken down by the body without the need for surgical removal or applied topically.
